Immunotherapy Drug Keytruda Approved For Colon Cancer Patients With Specific Tumor Abnormalities

Updated April 13th, 2022

Immunotherapy Drug Keytruda Approved For Colon Cancer Patients With Specific Tumor Abnormalities

A new option for the treatment of metastatic colorectal cancer, immune checkpoint inhibitor Keytruda, has been approved by the FDA -- marking historic progress for certain patients

NOW
PLAYING
Promising Targeted Therapy, Padcev, Falls Short of Meeting Goals for Advanced Breast Cancer - But May Still Have Future Treating Disease
NOW
PLAYING
More Progress With Less Intensive Treatment, Crucial New Research For People Battling Cancers Like Ovarian, Esophageal, & Hodgkin Lymphoma
NOW
PLAYING
New Pan-Tumor Approval For Targeted Drug Enhertu: Industry Leader Ashley Gaines Says Many More Oncologists & Patients Need To Be Aware of HER2 Testing
NOW
PLAYING
Advances in Next Generation Sequencing and Immunotherapy for Endometrial Cancer: Tailored Treatments and Key Considerations
NOW
PLAYING
Immunotherapy Provides Hope for Women With Advanced Endometrial Cancer
NOW
PLAYING
How is Immunotherapy Used for Advanced or Recurrent Endometrial Cancer?

Patient Pathfinder:

Clinical Trial Finder

Are you looking for other treatment options?
Right now there are ... colon cancer trials in the U.S. within 100 miles of

Enter your zip code and travel distance to explore trials in your area...

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.